Neang S Ly
6PUBLICATIONS
0CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Mar 04, 2023
Population Pharmacokinetics and Exposure-Response Analysis for the Phase 3 COSMIC-311 Trial of Cabozantinib for Radioiodine-Refractory Differentiated Thyroid Cancer.Neang S Ly, Jing Li, Raffaella Faggioni
|Jan 19, 2017
Influence of <i>rhlR</i> and <i>lasR</i> on Polymyxin Pharmacodynamics in Pseudomonas aeruginosa and Implications for Quorum Sensing Inhibition with Azithromycin.Zackery P Bulman, Neang S Ly, Justin R Lenhard
|Nov 01, 2016
Population Pharmacokinetics and Target Attainment of Ertapenem in Plasma and Tissue Assessed via Microdialysis in Morbidly Obese Patients after Laparoscopic Visceral Surgery.Mathias Wittau, Stephan Paschke, Max Kurlbaum
|Mar 02, 2016
Optimization of Polymyxin B in Combination with Doripenem To Combat Mutator Pseudomonas aeruginosa.Neang S Ly, Zackery P Bulman, Jürgen B Bulitta
|Apr 29, 2015
Emergence of polymyxin B resistance influences pathogenicity in Pseudomonas aeruginosa mutators.Zackery P Bulman, Mark D Sutton, Neang S Ly
|Feb 04, 2015
Two mechanisms of killing of Pseudomonas aeruginosa by tobramycin assessed at multiple inocula via mechanism-based modeling.Jürgen B Bulitta, Neang S Ly, Cornelia B Landersdorfer
Pageof 1
